Vivo Capital (US/CN)

https://www.vivocapital.net

Founded in 1996, Vivo Capital is a global investment firm focused on healthcare. Vivo has approximately $5.8 billion in assets under management, invested in over 310 public and private companies worldwide. The firm is headquartered in Palo Alto, California, with additional offices in Asia. The Vivo team consists of more than 50 multi-disciplinary professionals, including, physicians, scientists, entrepreneurs, operating executives, and industry experts. Vivo provides a multi-fund investment platform, covering growth equity, private equity including buyout, venture capital, and public equity. Vivo invests broadly in healthcare across all fund strategies, including biotechnology, pharmaceuticals, medical devices, and healthcare services, with a focus on the largest healthcare markets. *

	Start	1996-01-01 established
	Industry	venture capital
	Industry 2	LIFE SCIENCES
	Person	Yu, Chen (TCG Crossover 202107 Managing Partner + Founder before Vivo Capital 201504 Managing Partner)

	Street	575 High Street Suite 201
	City	94301 Palo Alto, CA
	Tel	+1-650-688-0818
		Address record changed: 2020-12-02

Basic data	Employees	n. a.
	Currency	USD
	Annual sales	5,800,000,000 (capital under management (2021) 2021-11-29)

		* Document for »About Section«: Ablaze Pharmaceuticals. (11/29/21). "Press Release: Ablaze Pharmaceuticals Launches with $75m Series A Financing to Bring Novel Targeted Radiopharmaceuticals to Treat Cancer Patients in the Greater China Market". Shanghai & San Diego, CA.

		Record changed: 2024-02-10

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x200px

More documents for Vivo Capital (US/CN)

[1] Terns Pharmaceuticals, Inc.. (10/30/18). "Press Release: Terns Pharmaceuticals Completes $80 Million Series B Financing to Advance Pipeline of Drugs to Treat NASH and Cancer". San Mateo, CA & Shanghai....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]